The effect of early statin treatment on inflammation and cardiac events in acute coronary syndrome patients with low-density lipoprotein cholesterol

Heart and Vessels

Volumn 21, Issue 5, 2006, Pages 291-297

  Kanadaşi, Mehmet ^a   Çayli, Murat ^a   Demirtaş, Mustafa ^a   Inal, Tamer ^a   Demir, Mesut ^a   Koç, Mevlut ^a   Avkaroǧullari, Mahir ^a   Dönmez, Yurdaer ^a   Usal, Ayhan ^a   Alhan, Cumhur C ^a   Şan, Mustafa ^a  

^a CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Acute coronary syndrome; Atorvastatin; Inflammation

Indexed keywords

ACETYLSALICYLIC ACID; AMYLOID A PROTEIN; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCERYL TRINITRATE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRATE; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY RECANALIZATION; EARLY INTERVENTION; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART FAILURE; HEART PROTECTION; HEART REINFARCTION; HOSPITAL READMISSION; HUMAN; INCIDENCE; INFLAMMATION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK REDUCTION; SIDE EFFECT; THORAX PAIN; UNSPECIFIED SIDE EFFECT; UNSTABLE ANGINA PECTORIS;

ACUTE DISEASE; AGED; ANTICHOLESTEREMIC AGENTS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HEPTANOIC ACIDS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; PYRROLES; SERUM AMYLOID A PROTEIN; STATISTICS; SYNDROME; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 33845345222     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-005-0901-1     Document Type: Article

References (24)

1. CJ Pepine 2003 Optimizing lipid management in patients with acute coronary syndromes Am J Cardiol 91 suppl 30B-35B 10.1016/ S0002-9149(02)03290-3 1:CAS:528:DC%2BD3sXisVWntL8%3D 12615296
2. GJ Blake PM Ridker 2001 Novel clinical markers of vascular wall inflammation Circ Res 89 763-771 1:CAS:528:DC%2BD3MXot1ynu70%3D 11679405
3. TP Zwaka V Hombach J Torzewski 2001 C-reactive protein-mediated low density lipoprotein uptake by macrophages: Implications for atherosclerosis Circulation 103 1194-1197 1:CAS:528:DC%2BD3MXisFeksLo%3D 11238260
4. L Lacoste JY Lam J Hung G Letchacovski CB Solymoss D Waters 1995 Hyperlipidemia and coronary disease: Correction of the increased thrombogenic potential with cholesterol reduction Circulation 92 3172-3177 1:CAS:528:DyaK28XhslOktQ%3D%3D 7586300
5. A Notarbartolo G Davi M Averna CM Barbagallo A Ganci C Giammarresi FP La Placa C Patrono 1995 Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia Arterioscler Thromb 15 247-251 1:STN:280:ByqB28fpsFE%3D
6. U Laufs V La Fata J Plutzky JK Liao 1998 Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors Circulation 97 1129-1135 1:CAS:528:DyaK1cXisVWmsrY%3D 9537338
7. PM Ridker N Rifai MA Pfeffer FM Sacks LA Moye S Goldman GC Flaker E Braunwald 1998 Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol And Recurrent Events (CARE) Investigators Circulation 98 839-844 1:CAS:528:DyaK1cXlvFyhur0%3D 9738637
8. Scandinavian Simvastatin Survival Study (4S) 1994 Randomised trial of cholesterol lowering in 4-444 patients with coronary heart disease Lancet 344 1383-1389 10.1016/S0140-6736(94)90566-5
9. The Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group 1998 Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels N Engl J Med 339 1349-1357 10.1056/ NEJM199811053391902
10. FM Sacks MA Pfeffer LA Moye JL Rouleau JD Rutherford TG Cole L Brown JW Warnica JM Arnold CC Wun BR Davis E Braunwald 1996 The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels N Engl J Med 335 1001-1009 10.1056/ NEJM199610033351401 1:CAS:528:DyaK28XmsFWls7c%3D 8801446
11. HR Arntz R Agrawal W Wunderlich L Schnitzer R Stern F Fischer HP Schultheiss 2000 Beneficial effects of pravastatin (6colestyramine/ niacin) initiated immediately after a coronary event (the Randomized Lipid-Coronary Artery Disease [L-CAD] Study) Am J Cardiol 86 1293-1298 10.1016/S0002-9149(00)01230-3 1:CAS:528:DC%2BD3cXoslGgs7k%3D 11113401
12. GG Schwartz AG Olsson MD Ezekowitz P Ganz MF Oliver D Waters A Zeiher BR Chaitman S Leslie T Stern Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators 2001 Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: TAe MIRACL study: a randomized controlled trial JAMA 285 1711-1718 10.1001/jama.285.13.1711 1:CAS:528:DC%2BD3MXivFGnurc%3D 11277825
13. U Stenestrand L Wallentin 2001 Swedish Register of Cardiac Intensive Care (RIKS-HIA). Early statin treatment following acute myocardial infarction and 1-year survival JAMA 285 430-436 10.1001/jama.285.4.430 1:CAS:528:DC%2BD3MXhtVehu7c%3D 11242427
14. M Kayikcioǧlu L Can H Kultursay S Payzin C Turkoglu 2002 Early use of pravastatin with acute myocardial infarction undergoing coronary angioplasty Acta Cardiol 57 295-302 10.2143/AC.57.4.2005430 12222700
15. SM Grundy JI Cleeman CN Merz HB Brewer Jr LT Clark DB Hunninghake RC Pasternak SC Smith Jr NJ Stone 2004 National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 110 227-239 10.1161/01.CIR.0000133317.49796.0E 15249516
16. CP Cannon E Braunwald CH McCabe DJ Rader JL Rouleau R Belder SV Joyal KA Hill MA Pfeffer AM Skene Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators 2004 Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med 350 1495-1504 10.1056/NEJMoa040583 1:CAS:528:DC%2BD2cXjtVeqtr8%3D 15007110
17. F Avanzini G Ferrario L Santoro P Peci P Giani E Santoro MG Franzosi G Tognoni Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico-3 Investigators 2002 Risks and benefits of early treatment of acute myocardial infarction with an angiotensin-converting enzyme inhibitor in patients with a history of arterial hypertension: Analysis of the GISSI-3 database Am Heart J 144 1018-1025 10.1067/mhj.2002.126739 1:CAS:528:DC%2BD3sXnvFSq 12486426
18. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group 1995 ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58-050 patients with suspected acute myocardial infarction Lancet 345 669-685 10.1016/S0140-6736(95)90865-X
19. T Killip J Kimball 1967 Treatment of myocardial infarction in a coronary care unit: A two year experience with 250 patients Am J Cardiol 20 45710.1016/0002-9149(67)90023-9 6059183
20. New York Heart Association 1994 The Criteria Committee of the New York Heart Association Nomenclature and Criteria for Diagnosis, 9th edn Little Brown Boston
21. EM Macy TE Hayes RP Tracy 1997 Variability of measurement of C-reactive protein in healthy subjects: Implications for reference interval and epidemiological interval Clin Chem 43 52-58 1:CAS:528:DyaK2sXis1Kltg%3D%3D 8990222
22. S Poole D Walker RE Gaines Das RJ Gallimore MB Pepys 1998 The first international standard for serum amyloid A protein (SAA). Evaluation in an international collaborative study J Immunol Methods 214 1-10 10.1016/ S0022-1759(98)00057-X 1:CAS:528:DyaK1cXjvVSksbs%3D 9692853
23. T Matsuo K Iwade N Hirata M Yamashita H Ikegami N Tanaka M Aosaki H Kasanuki 2005 Improvement of arterial stiffness by the antioxidant and anti-inflammatory effects of short-term statin therapy in patients with hypercholesterolemia Heart Vessels 20 8-12 10.1007/s00380-004-0793-5 15700196
24. Y Luo D Jiang D Wen J Yang L Li 2004 Changes in serum interleukin-6 and high-sensivity C-reactive protein levels in patients with acute coronary syndrome and their responses to simvastatin Heart Vessels 19 257-262 10.1007/s00380-004-0776-6 15799170